Safety and antitumor activity of hypofractionated stereotactic irradiation (HFSRT) with pembrolizumab (Pembro) and bevacizumab (Bev) in patients (pts) with recurrent high grade gliomas: Preliminary results from phase I study.

被引：4
|
作者：
Sahebjam, Solmaz
Johnstone, Peter A.
Forsyth, Peter A. J.
Arrington, John
Vrionis, Frank D.
Etame, Arnold B.
Tran, Nam D.
Dalvi, Pranali H.
Kim, Sungjune
Macaulay, Roberti
Chinnaiyan, Prakash
Yu, Michael
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[3] Beaumont Hlth Syst, Dearborn, MI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.2041
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2041
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A PHASE I TRIAL OF HYPOFRACTIONATED STEREOTACTIC IRRADIATION (HFSRT) COMBINED WITH NIVOLUMAB (NIVO), IPILIMUMAB (IPI) AND BEVACIZUMAB (BEV) IN PATIENTS (PTS) WITH RECURRENT HIGH GRADE GLIOMAS
    Sahebjam, Solmaz
    Forsyth, Peter
    Nam Tran
    Etame, Arnold
    Arrington, John
    Jaglal, Michael
    Mokhtari, Sepideh
    MacAulay, Robert
    Wicklund, Melissa
    Evernden, Brittany
    Gatewood, Tyra
    Robinson, Timothy
    Raval, Raju
    Yu, Michael
    [J]. NEURO-ONCOLOGY, 2019, 21 : 5 - 5
  • [2] Hypofractionated stereotactic re-irradiation with pembrolizumab and bevacizumab in patients with recurrent high-grade gliomas: results from a phase I study
    Sahebjam, Solmaz
    Forsyth, Peter A.
    Tran, Nam D.
    Arrington, John A.
    Macaulay, Robert
    Etame, Arnold B.
    Walko, Christine M.
    Boyle, Theresa
    Peguero, Edwin N.
    Jaglal, Michael
    Mokhtari, Sepideh
    Enderling, Heiko
    Raghunand, Natarajan
    Gatewood, Tyra
    Long, Wendy
    Dzierzeski, Jennifer L.
    Evernden, Brittany
    Robinson, Timothy
    Wicklund, Melissa C.
    Kim, Sungjune
    Thompson, Zachary J.
    Chen, Dung-Tsa
    Chinnaiyan, Prakash
    Yu, Hsiang-Hsuan Michael
    [J]. NEURO-ONCOLOGY, 2021, 23 (04) : 677 - 686
  • [3] A PHASE I TRIAL OF HYPOFRACTIONATED STEREOTACTIC IRRADIATION (HFSRT) WITH PEMBROLIZUMAB AND BEVACIZUMAB IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA (NCT02313272)
    Sahebjam, Solmaz
    Forsyth, Peter
    Arrington, John
    Jaglal, Michael
    Tran, Nam D.
    Etame, Arnold B.
    Wicklund, Melissa
    Drury-Sibiga, Ali
    Long, Wendy
    Evernden, Brittany
    Gatewood, Tyra
    Macaulay, Robert
    Chinnaiyan, Prakash
    Yu, Michael
    [J]. NEURO-ONCOLOGY, 2017, 19 : 30 - 30
  • [4] Nivolumab combined with hypofractionated stereotactic irradiation (HFSRT) for patients with recurrent high grade gliomas: A phase I trial (NCT02829931).
    Sahebjam, Solmaz
    Forsyth, Peter A. J.
    Arrington, John
    Tran, Nam D.
    Jaglal, Michael Vishal
    Mokhtari, Sepideh
    Long, Wendy
    Macaulay, Robert J.
    Wicklund, Melissa
    Drury-Sibiga, Ali
    Gatewood, Tyra
    Robinson, Timothy J.
    Raval, Raju R.
    Yu, Michael
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] Antitumor activity and safety of MK-1308 (anti-CTLA-4) plus pembrolizumab (pembro) in patients (pts) with non-small cell lung cancer (NSCLC): Updated interim results from a phase I study.
    Perets, Ruth
    Yoh, Kiyotaka
    Kim, Dong-Wan
    Bar, Jair
    Ahn, Myung-Ju
    Nagrial, Adnan
    Satouchi, Miyako
    Rasco, Drew W.
    Lee, Dae Ho
    Spigel, David R.
    Kotasek, Dusan
    Gutierrez, Martin
    Niu, Jiaxin
    Siddiqi, Shabana
    Chain, Anne
    Butts, Brent D.
    Li, Xiaoyun Nicole
    Cyrus, Jobin
    Altura, Rachel
    Cho, Byoung Chul
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [6] Antitumor activity and safety of pembrolizumab in patients (pts) with PD-L1 positive advanced ovarian cancer: Interim results from a phase Ib study.
    Varga, Andrea
    Piha-Paul, Sarina Anne
    Ott, Patrick Alexander
    Mehnert, Janice M.
    Berton-Rigaud, Dominique
    Johnson, Elizabeth A.
    Cheng, Jonathan D.
    Yuan, Sammy
    Rubin, Eric H.
    Matei, Daniela E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [7] Phase I study of panobinostat and fractionated stereotactic re-irradiation therapy (FSRT) for recurrent high grade gliomas
    Shi, W.
    Lawrence, Y. R.
    Werner-Wasik, M.
    Andrews, D. W.
    Evans, J. J.
    Glass, J.
    Kim, L.
    Bar Ad, V.
    Moshel, Y.
    Judy, K.
    Farrell, C.
    Simon, N. L.
    Dicker, A. P.
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 : 73 - 73
  • [8] PHASE I STUDY OF PANOBINOSTAT AND FRACTIONATED STEREOTACTIC RE-IRRADIATION THERAPY (FSRT) FOR RECURRENT HIGH GRADE GLIOMAS
    Shi, Wenyin
    Lawrence, Yaacov Richard
    Werner-Wasik, Maria
    Evans, James
    Andrews, David
    Glass, Jon
    Kim, Lyndon
    Bar Ad, Voichita
    Moshel, Yaron
    Judy, Kevin
    Farrell, Christopher
    Simon, Nicole
    Dicker, Adam
    [J]. NEURO-ONCOLOGY, 2014, 16
  • [9] Futibatinib plus pembrolizumab in patients (pts) with advanced or metastatic urothelial carcinoma (mUC): Preliminary safety results from a phase 2 study.
    Koshkin, Vadim S.
    Sonpavde, Guru P.
    Hwang, Clara
    Mellado, Begona
    Tomlinson, Gareth
    Shimura, Masashi
    Chisamore, Michael Jon
    Gil, Maciej
    Loriot, Yohann
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [10] Efficacy and safety of bevacizumab (BEV) plus chemotherapy in Chinese patients (pts) with metastatic colorectal cancer (mCRC): Results from the ARTIST study.
    Guan, Z.
    Xu, J.
    Luo, R.
    Feng, F.
    Wang, L.
    Shen, L.
    Yu, S.
    Ba, Y.
    Liang, J.
    Wang, D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345